TCM
CRL icon

Teza Capital Management’s Charles River Laboratories CRL Stock Holding History

Teza Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,847
Closed -$710K – 429
2024
Q4 		$710K Buy
+3,847
New +$741K 0.11% 236
2024
Q3 		– Sell
-4,849
Closed -$1M – 623
2024
Q2 		$1M Buy
+4,849
New +$1.1M 0.12% 240
2019
Q1 		– Sell
-10,077
Closed -$1.14M – 318
2018
Q4 		$1.14M Buy
10,077
+917
+10% +$115K 0.43% 69
2018
Q3 		$1.23M Buy
9,160
+1,753
+24% +$216K 0.28% 133
2018
Q2 		$832K Buy
+7,407
New +$801K 0.12% 301

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return